Organizations  >  Argos Therapeutics, Inc.

Argos Therapeutics, Inc. P11

DC-THERA Partner  
Argos Therapeutics, Inc. is developing breakthrough immunotherapies that target unique features of a patient’s disease. This new generation of personalized cancer and infectious disease therapeutics trains the immune system to recognize and attack the disease. Argos’ scientific leadership in RNA-loaded dendritic cells and advanced manufacturing processes provide a platform to tackle virtually all forms of cancers and infectious diseases.

Argos, a private biotechnology company, is headquartered in Research Triangle Park, NC. The Company has clinical trial programs in cancer and human immunodeficiency virus (HIV) and has an ongoing co-development and commercialization alliance with the Pharmaceutical Division of Kirin Brewery Company, Limited.
Affiliated Persons
Scientific responsible
Contact Information
Vcard download vcard
Phone +1 (919) 287-6300
Address 4233 Technology Drive
Durham (North Carolina)

  [ RDF Rdf ]